Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR) did not meet its primary endpoint.
"Our analysis of the overall data in this program and the current competitive environment in allergic rhinitis indicate that epinastine nasal spray does not show potential to meet our desired product profile in the United States," stated Christy L. Shaffer, Ph.D., President Read more…
Posted by poster under
Uncategorized
Buy generic clomid An estimated 50 million Americans suffer from the miseries of allergies, with allergic reactions involving the eyes a common complaint. For many, symptoms of eye allergies can be so uncomfortable and irritating that they interfere with job Read more…
Posted by poster under
Uncategorized
Over five million of the 13 million hay fever sufferers across Britain could be taking
inappropriate medicines, putting their health at risk. The Royal Pharmaceutical Society of
(RPSGB) is encouraging people experiencing the symptoms of hay fever to visit
their community pharmacist after new research revealed that the public often misdiagnose the
condition and fail to get the correct treatment.
Allergic rhinitis, known Read more…
Posted by poster under
Uncategorized
The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.
When it is green and the flowers have returned, the allergy season has hit its peak. And the number of people affected is still rising. At least 1 in 5 people in Germany get Read more…
Posted by poster under
Uncategorized